Skip to main content
Article
Conversion of Urine Protein-Creatinine Ratio or Urine Dipstick Protein to Urine Albumin-Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis: An Individual Participant-Based Meta-analysis.
Annals of internal medicine
  • Keiichi Sumida
  • Girish N Nadkarni
  • Morgan E Grams
  • Yingying Sang
  • Shoshana H Ballew
  • Josef Coresh
  • Kunihiro Matsushita
  • Aditya Surapaneni
  • Nigel Brunskill
  • Steve J Chadban
  • Alex R Chang
  • Massimo Cirillo
  • Kenn B Daratha, Providence Health Care, Nephrology Division, Kidney Research Institute, Spokane, Washington
  • Ron T Gansevoort
  • Amit X Garg
  • Licia Iacoviello
  • Takamasa Kayama
  • Tsuneo Konta
  • Csaba P Kovesdy
  • James Lash
  • Brian J Lee
  • Rupert W Major
  • Marie Metzger
  • Katsuyuki Miura
  • David M J Naimark
  • Robert G Nelson
  • Simon Sawhney
  • Nikita Stempniewicz
  • Mila Tang
  • Raymond R Townsend
  • Jamie P Traynor
  • José M Valdivielso
  • Jack Wetzels
  • Kevan R Polkinghorne
  • Hiddo J L Heerspink
Document Type
Article
Publication Date
7-14-2020
Abstract

BACKGROUND: Although measuring albuminuria is the preferred method for defining and staging chronic kidney disease (CKD), total urine protein or dipstick protein is often measured instead.

OBJECTIVE: To develop equations for converting urine protein-creatinine ratio (PCR) and dipstick protein to urine albumin-creatinine ratio (ACR) and to test their diagnostic accuracy in CKD screening and staging.

DESIGN: Individual participant-based meta-analysis.

SETTING: 12 research and 21 clinical cohorts.

PARTICIPANTS: 919 383 adults with same-day measures of ACR and PCR or dipstick protein.

MEASUREMENTS: Equations to convert urine PCR and dipstick protein to ACR were developed and tested for purposes of CKD screening (ACR ≥30 mg/g) and staging (stage A2: ACR of 30 to 299 mg/g; stage A3: ACR ≥300 mg/g).

RESULTS: Median ACR was 14 mg/g (25th to 75th percentile of cohorts, 5 to 25 mg/g). The association between PCR and ACR was inconsistent for PCR values less than 50 mg/g. For higher PCR values, the PCR conversion equations demonstrated moderate sensitivity (91%, 75%, and 87%) and specificity (87%, 89%, and 98%) for screening (ACR >30 mg/g) and classification into stages A2 and A3, respectively. Urine dipstick categories of trace or greater, trace to +, and ++ for screening for ACR values greater than 30 mg/g and classification into stages A2 and A3, respectively, had moderate sensitivity (62%, 36%, and 78%) and high specificity (88%, 88%, and 98%). For individual risk prediction, the estimated 2-year 4-variable kidney failure risk equation using predicted ACR from PCR had discrimination similar to that of using observed ACR.

LIMITATION: Diverse methods of ACR and PCR quantification were used; measurements were not always performed in the same urine sample.

CONCLUSION: Urine ACR is the preferred measure of albuminuria; however, if ACR is not available, predicted ACR from PCR or urine dipstick protein may help in CKD screening, staging, and prognosis.

PRIMARY FUNDING SOURCE: National Institute of Diabetes and Digestive and Kidney Diseases and National Kidney Foundation.

Clinical Institute
Kidney & Diabetes
Specialty
Internal Medicine
Specialty
Endocrinology
Citation Information
Keiichi Sumida, Girish N Nadkarni, Morgan E Grams, Yingying Sang, et al.. "Conversion of Urine Protein-Creatinine Ratio or Urine Dipstick Protein to Urine Albumin-Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis: An Individual Participant-Based Meta-analysis." Annals of internal medicine (2020)
Available at: http://works.bepress.com/kenn-daratha/24/